Clinical Trials

Showing trials with last updates posted in 2026.

NCT06336304 | TERMINATED
163 participants

NXT Post-Market Clinical Follow-up

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-31
Start Date:
2024-06-18
Completion:
2026-06-30
Conditions
  • Urinary Incontinence
  • Urinary Obstruction
  • Urinary Bladder, Overactive
  • Urinary Bladder, Neurogenic
  • Urinary Incontinence, Urge
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT06236321 | COMPLETED | NA
15 participants

The Microbrect-FFC Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2022-11-04
Completion:
2024-05-31
Conditions
  • Colorectal Cancer
Interventions
  • OTHER
No Results Yet
NCT06172478 | RECRUITING | PHASE2
740 participants

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-02-26
Completion:
2027-09-01
Conditions
  • Advanced Solid Tumor
  • Melanoma
  • Head and Neck Cancer
  • Gastric Cancer
  • Ovarian Carcinoma
  • Cervical Cancer
  • Endometrial Cancer
  • Bladder Cancer
  • Esophageal Cancer
  • Pancreatic Carcinoma
  • Prostate Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Lung Cancer
  • Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT06138275 | RECRUITING | PHASE2
32 participants

Elranatamab in R/R Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-03-08
Completion:
2027-12-01
Conditions
  • Refractory Multiple Myeloma
  • Relapse Multiple Myeloma
  • Multiple Myeloma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page